The DECIDER project represents an international and interdisciplinary research activity working towards defining new approaches for personalised medicine in ovarian cancer treatments, overcoming the challenges of health data sharing and data interoperability.

The Clinical Decision via Integrating Multiple Data Levels to Overcome Chemotherapy Resistance in High- Grade Serous Ovarian Cancer, also called DECIDER project, is an EU funded international and interdisciplinary research project studying the chemotherapy resistance in ovarian cancer patients. The aims of the research are to develop tools to identify resistant patients and to discover effective combination of treatments based on the measured data.

Tackling interoperability challenges, the team will develop an open-source software where all the relevant data from a patient will be integrated and visualised to support clinical decision-making. Moreover, although data used in the research come from patients treated in Finland, the consortium includes 14 participants across Europe, therefore promoting data sharing in health research through the implementation of data pseudonymisation and anonymisation techniques to manage sensitive patient data.